monoclonal antibody 7.7 (α-exp2) (European Malaria Reagent)
Structured Review
Monoclonal Antibody 7.7 (α Exp2), supplied by European Malaria Reagent, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/exp2/mouse+anti+exp2/pm40198740-473-0-8
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Characterization and MicroRNA Quantification of Plasma-derived Extracellular Vesicles in Patients with Plasmodium knowlesi infection Article Snippet: The anti-mouse EXP-2 (The Article Title: HOPS/CORVET tethering complexes are critical for endocytosis and protein trafficking to invasion related organelles in malaria parasites. Article Snippet: Article Title: Malaria parasite HOPS/CORVET complexes are critical for endocytosis and invasion organelles function Article Snippet: Samples were labelled with the primary antibodies: Article Title: Characterization and microRNA quantification of plasma-derived extracellular vesicles in patients with Plasmodium knowlesi infection Article Snippet: The anti-mouse EXP-2 (The Article Title: PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults Article Snippet: Article Title: HOPS/CORVET tethering complexes are critical for endocytosis and protein trafficking to invasion related organelles in malaria parasites Article Snippet: Samples were labelled with the primary antibodies: Article Title: HOPS/CORVET tethering complexes are critical for endocytosis and protein trafficking to invasion related organelles in malaria parasites. Article Snippet: Samples were labelled with the primary antibodies: Article Title: PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults. Article Snippet: Monoclonal antibody 7.7 (anti-EXP-2) was obtained from The |
![Schematic representation of the experimental design of the study. Six hundred one-day-old broiler chickens Ross AP were distributed in four experiments (EXP) (150 chickens for each Experiment) [EXP1: no vaccine; <t>EXP2:</t> NDV vaccine virus (NOBILIS ND clone 30); EXP3: IBDV vaccine virus (Hipragumboro strain Winterfield clone CH/80), and EXP4: IBV vaccine virus (Hipraviar H120)]. The 150 chickens were randomly distributed in the 15 pens (ten chickens per pen), considering each pen an experimental unit. In each EXP, the following treatments were applied: T1 (Control): distilled water as a spray; T2 (EO blend): EO mixture (1,500 ppm in spray); T3 (EO Lippia alba ): Lippia alba essential oil (1,500 ppm in spray).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2989/pmc12722989/pmc12722989__gr1.jpg)